---
title: "PAFAH1B3"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Brief Information about Gene PAFAH1B3"
tags: ['PAFAH1B3', 'LIS1', 'NeuronalMigration', 'MillerDiekerSyndrome', 'Antipsychotics', 'PersonalizedMedicine', 'GeneticProfile', 'NeuralDevelopment']
---

# Brief Information about Gene PAFAH1B3

## Gene Position, Pathology, and Function
Gene PAFAH1B3 is located on chromosome 19p13.3 and its expression is observed in various tissues including brain, heart, liver, kidney and lungs. This gene is also known as PLPBP (PLP-binding protein) and is involved in protein-protein interactions. It is encoded by the PAFAH1B3 gene and is also referred to as LIS1 protein. This protein is a required component of dynein-mediated transport of vesicles and organelles. 

## Function
The PAFAH1B3 gene encodes for the LIS1 protein and is involved in the regulation of neuronal migration, division and differentiation. This protein has been shown to be implicated in neural development and disorders of the human nervous system.

## External IDs and Aliases
- HGNC: 8623
- NCBI Entrez: 5048
- Ensembl: ENSG00000179271
- OMIM: 601545
- UniProtKB/Swiss-Prot: Q15078
- Aliases: LIS1, PAFAH, MDCR, Miller-Dieker syndrome critical region gene 1, lissencephalin-1

## AA Mutation List and Mutation Type with dbSNP ID
- c.1A > G (p.Met1Val) missense variant, rs1260894624
- c.157C > A (p.Ala53Glu) nonsynonymous SNV, rs863224564
- c.212C > T (p.Ala71Val) nonsynonymous SNV, rs200477941
- c.355G > A (p.Ala119Thr) nonsynonymous SNV, rs139913303
- c.493T > C (p.Ile165Thr) nonsynonymous SNV, rs372567202
- c.532C > T (p.Ser178Phe) nonsynonymous SNV, rs267606837
- c.628G > A (p.Ala210Thr) nonsynonymous SNV, rs885831063
- c.748G > A (p.Ala250Thr) nonsynonymous SNV, rs750008712
- c.815G > A (p.Arg272Gln) nonsynonymous SNV, rs786204750
- c.831T > C (p.Leu277Pro) nonsynonymous SNV, rs758074311

## Somatic SNVs/InDels with dbSNP ID
- c.152-131_5+666del indel, rs755519686
- c.152-131_5+666dup indel, rs767639631

## Related Disease
PAFAH1B3 is associated with a variety of diseases, including:
- Miller-Dieker lissencephaly syndrome
- subcortical band heterotopia
- schizophrenia
- bipolar disorder
- major depression disorder

## Treatment and Prognosis
Currently, there is no cure for diseases related to PAFAH1B3 mutations. However, treatment can alleviate some of the symptoms associated with the disease. Treatment usually involves a combination of medications, such as anticonvulsants, antipsychotics, and antidepressants and therapies, like physical, occupational, and speech therapy.

## Drug Response
Studies have shown that individuals with PAFAH1B3 mutations may respond differently to certain medications, such as antipsychotics. Researchers are exploring the possibility of personalized medicine based on an individual's genetic profile.

## Related Papers
- Hirotsune S, Fleck MW, Gambello MJ, Bix GJ, Chen A, Clark GD, Ledbetter DH, McBain CJ, Wynshaw-Boris A. (1998) "Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality." Nature Genetics 19(4):333-9. PMID: 9697693.
- Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns WB, Caskey CT, Ledbetter DH. (1993) "Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats." Nature 364(6439):717-21. PMID: 8395024.
- Yingling J, Youn YH, Darling D, Toyo-Oka K, Pramparo T, Hirotsune S, Wynshaw-Boris A. (2008) "Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division." Cell 132(3):474-86. PMID: 18267072.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**